Literature DB >> 8360714

Primary diffuse leptomeningeal gliomatosis (PDLG): a neoplastic cause of chronic meningitis.

P Y Dietrich1, M S Aapro, A Rieder, G P Pizzolato.   

Abstract

Cancerous 'chronic meningitis' may be related to subarachnoid space involvement by solid tumors, hematologic malignancies or rarely intraparenchymatous gliomas. Primary leptomeningeal gliomatosis is a rare condition that is attributed to malignant transformation of heterotopic neuroglial tissue. We discuss the clinical and biological features of a patient who died with the diffuse form of primary leptomeningeal gliomatosis (PDLG). A literature search shows that a one to two months long non-specific prodromal phase followed by a fluctuating neurologic downhill course is suggestive of this disease. Cerebro-spinal fluid (CSF) cytology has been diagnostic in only 1 of 8 reported cases. Recent technical progress, including the use of GFAP (glial fibrillary acidic protein) directed antibody, may enhance the sensitivity of CSF cytologies. Diagnosis may require repeated cerebral biopsies, because the hemispheric lesions are often separated by normal tissue. PDLG must be added to the large differential diagnosis of 'chronic meningitis'.

Entities:  

Mesh:

Year:  1993        PMID: 8360714     DOI: 10.1007/bf01050075

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  39 in total

1.  Tumors of the spinal cord; primary extramedullary gliomas.

Authors:  I S COOPER; W M CRAIG; J W KERNOHAN
Journal:  Surg Gynecol Obstet       Date:  1951-02

2.  "Chronic meningitis"--many causes to consider.

Authors:  M N Swartz
Journal:  N Engl J Med       Date:  1987-10-08       Impact factor: 91.245

3.  Central nervous system complications in patients with diffuse histiocytic and undifferentiated lymphoma: leukemia revisited.

Authors:  P A Bunn; P S Schein; P M Banks; V T DeVita
Journal:  Blood       Date:  1976-01       Impact factor: 22.113

4.  Meningeal carcinomatosis in patients with primary breast or lung cancer.

Authors:  S C Sorensen; R T Eagan; M Scott
Journal:  Mayo Clin Proc       Date:  1984-02       Impact factor: 7.616

5.  Leptomeningeal metastasis from supratentorial malignant gliomas.

Authors:  I Awad; J W Bay; L Rogers
Journal:  Neurosurgery       Date:  1986-08       Impact factor: 4.654

6.  Diffuse leptomeningeal gliomatosis: report of three cases.

Authors:  H T Whelan; J H Sung; A R Mastri
Journal:  Clin Neuropathol       Date:  1987 Jul-Aug       Impact factor: 1.368

7.  Extracerebral leptomeningeal astrocytoma mimicking a meningioma.

Authors:  D S Horoupian; F Lax; K Suzuki
Journal:  Arch Pathol Lab Med       Date:  1979-12       Impact factor: 5.534

8.  Solitary, primary malignant astrocytoma of the spinal leptomeninges.

Authors:  U P Kalyan-Raman; P A Cancilla; M J Case
Journal:  J Neuropathol Exp Neurol       Date:  1983-09       Impact factor: 3.685

9.  Primary leptomeningeal gliomatosis and "numb, clumsy hands": a case report.

Authors:  B Blumenkopf; J Gutierrez; W Bennett
Journal:  Neurosurgery       Date:  1986-03       Impact factor: 4.654

10.  Cerebral vasculitis associated with hairy cell leukemia.

Authors:  J Lowe; N H Russell
Journal:  Cancer       Date:  1987-12-15       Impact factor: 6.860

View more
  16 in total

1.  A case report and review of the literature.

Authors:  Shoji Yomo; Tsuyoshi Tada; Shuichi Hirayama; Naoko Tachibana; Masako Otani; Yuichiro Tanaka; Kazuhiro Hongo
Journal:  J Neurooncol       Date:  2006-09-20       Impact factor: 4.130

2.  Primary diffuse leptomeningeal oligodendrogliomatosis causing sudden death.

Authors:  Ayca Ozkul; Ibrahim Meteoglu; Cengiz Tataroglu; Ali Akyol
Journal:  J Neurooncol       Date:  2006-11-01       Impact factor: 4.130

3.  Primary diffuse leptomeningeal gliomatosis in 2 dogs.

Authors:  Sara Canal; Marco Bernardini; Silvia Pavone; Maria T Mandara
Journal:  Can Vet J       Date:  2013-11       Impact factor: 1.008

4.  Leptomeningeal gliomatosis as the initial presentation of gliomatosis cerebri.

Authors:  Matthew K Knox; Cynthia Ménard; Warren P Mason
Journal:  J Neurooncol       Date:  2010-02-10       Impact factor: 4.130

Review 5.  Aggressive treatment with complete remission in primary diffuse leptomeningeal gliomatosis--a case report.

Authors:  P Beauchesne; J Pialat; R Duthel; F G Barral; G Clavreul; T Schmitt; B Laurent
Journal:  J Neurooncol       Date:  1998-04       Impact factor: 4.130

Review 6.  The leptomeninges as a critical organ for normal CNS development and function: First patient and public involved systematic review of arachnoiditis (chronic meningitis).

Authors:  Carol S Palackdkharry; Stephanie Wottrich; Erin Dienes; Mohamad Bydon; Michael P Steinmetz; Vincent C Traynelis
Journal:  PLoS One       Date:  2022-09-30       Impact factor: 3.752

7.  Primary diffuse leptomeningeal gliosarcomatosis.

Authors:  Yosuke Watanabe; Takuhiro Hotta; Hiroyuki Yoshioka; Yoko Itou; Kiyomi Taniyama; Kazuhiko Sugiyama
Journal:  J Neurooncol       Date:  2007-07-13       Impact factor: 4.506

8.  Long survival of primary diffuse leptomeningeal gliomatosis following radiotherapy and temozolomide: case report and literature review.

Authors:  Niels Hansen; A Wittig; J Hense; O Kastrup; E R Gizewski; J A P Van de Nes
Journal:  Eur J Med Res       Date:  2011-09-12       Impact factor: 2.175

9.  Disseminated primary diffuse leptomeningeal gliomatosis: a case report with liquid based and conventional smear cytology.

Authors:  Masha Bilic; Cynthia T Welsh; Zoran Rumboldt; Rana S Hoda
Journal:  Cytojournal       Date:  2005-09-20       Impact factor: 2.091

Review 10.  Meninges in cancer imaging.

Authors:  G Mahendru; V Chong
Journal:  Cancer Imaging       Date:  2009-10-02       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.